IDH1 and astrocytoma (excluding glioblastoma): Since this alteration does not have a known pathogenic association and other molecular alterations in this tumor were characteristic of an IDH-wildtype infiltrating astrocytoma, the mutation was regarded as clinically insignificant and not diagnostic of the IDH-mutated class of tumors.